6.550USD+2.99%Mkt Cap: 1.02B $P/E: —1d ago
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access i…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Cheaper
1M Perf
Lower
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
Indicators:|
Key Statistics
Company
Market Cap1.02B $
Enterprise Value1.17B $
Revenue (TTM)419.75M $
Gross Profit257.71M $
Net Income (TTM)-1.59M $
Revenue/Share2.630 USD
Last Price6.550 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)15.82
PEG—
EV/EBITDA12.49
EV/Revenue2.80
P/S2.43
P/B0.99
EPS (TTM)-0.10
EPS (Forward)0.41
52W Range
4.45022% of range13.88
52W High13.88 USD
52W Low4.450 USD
Profitability
Gross Margin61.53%
Oper. Margin3.80%
EBITDA Margin22.40%
Profit Margin-0.38%
ROE-0.15%
ROA-0.10%
Growth
Revenue Growth0.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF96.33M $
CapEx (TTM)26.56M $
FCF Margin27.77%
FCF Yield11.44%
Net Debt155.15M $
Net Debt/EBITDA1.65
Balance Sheet
Debt/Equity0.29
Current Ratio1.88
Quick Ratio1.78
Book Value/Sh6.633 USD
Cash/Share0.9610 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.480 USD
Upside (mean)+14.2%
Target Range6.000 USD – 10.00 USD
$6.000+14.2% to mean$10.00
# Analysts10
Ownership
Shares Out.155.56M
Float107.28M
Insiders2.57%
Institutions112.58%
Short Interest
Short Ratio7.2d
Short % Float28.41%
Short % Out.18.34%
Shares Short28.53M
Short (prev mo.)25.28M
Technical
SMA 505.612 (+16.7%)
SMA 2008.149 (-19.6%)
Beta1.49
S&P 52W Chg20.05%
Avg Vol (30d)4.04M
Avg Vol (10d)5.82M
Technical Indicators
RSI (14)67.4
MACD0.1546
MACD Signal0.0387
MACD Hist.+0.1158
BB Upper6.372 USD
BB Middle5.573 USD
BB Lower4.774 USD
BB Width28.68%
ATR (14)0.3946 USD
Vol Ratio (20d)1.16x